Search by Drug Name or NDC

NDC 17772-0122-07 OXTELLAR XR 300 mg/1 Details

OXTELLAR XR 300 mg/1

OXTELLAR XR is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Supernus Pharmaceuticals, Inc.. The primary component is OXCARBAZEPINE.

MedlinePlus Drug Summary

Oxcarbazepine (Trileptal) is used alone or in combination with other medications to control certain types of seizures in adults and children. Oxcarbazepine extended-release tablets (Oxtellar XR) are used in combination with other medications to control certain types of seizures in adults and children 6 years of age and older. Oxcarbazepine is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.

Related Packages: 17772-0122-07
Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Oxcarbazepine

Product Information

NDC	17772-0122
Product ID	17772-122_0cf4cb65-adb7-e3ca-e063-6294a90a3e30
Associated GPIs	72600046007530
GCN Sequence Number	070191
GCN Sequence Number Description	oxcarbazepine TAB ER 24H 300 MG ORAL
HIC3	H4B
HIC3 Description	ANTICONVULSANTS
GCN	33557
HICL Sequence Number	011735
HICL Sequence Number Description	OXCARBAZEPINE
Brand/Generic	Brand
Proprietary Name	OXTELLAR XR
Proprietary Name Suffix	n/a
Non-Proprietary Name	OXCARBAZEPINE
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	300
Active Ingredient Units	mg/1
Substance Name	OXCARBAZEPINE
Labeler Name	Supernus Pharmaceuticals, Inc.
Pharmaceutical Class	Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA202810
Listing Certified Through	2024-12-31

Package

NDC 17772-0122-07 (17772012207)

Pricing Information	N/A
NDC Package Code	17772-122-07
Billing NDC	17772012207
Package	7 TABLET in 1 BOTTLE (17772-122-07)
Marketing Start Date	2023-07-01
NDC Exclude Flag	N